Kanglexin protects against cardiac fibrosis and dysfunction in mice by TGF-β1/ERK1/2 noncanonical pathway

Cardiac fibrosis is a common pathological manifestation accompanied by various heart diseases, and antifibrotic therapy is an effective strategy to prevent diverse pathological processes of the cardiovascular system. We currently report the pharmacological evaluation of a novel anthraquinone compoun...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xue, Han, Weina, An, Na, Cao, Na, Wu, Tingting, Yang, Shuang, Ding, Lili, Chen, Xiaoli, Chen, Chao, Aruhan, Zhang, Yannan, Wang, Kexin, Suo, Lianhuan, Huang, Jian, Wang, Jinhui, Zhao, Xin, Zhu, Jiuxin, Zhang, Yan, Yang, Baofeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7840489/
https://www.ncbi.nlm.nih.gov/pubmed/33519438
http://dx.doi.org/10.3389/fphar.2020.572637

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7840489/
https://www.ncbi.nlm.nih.gov/pubmed/33519438
http://dx.doi.org/10.3389/fphar.2020.572637

Ejemplares similares